In this study, we have found through in silico analysis that the TGFβ signaling pathway is the most dysregulated pathway in glioblastoma, and ZEB2 is involved in this pathway mostly through interactions with SMAD2 and SMAD5. This evidence concerns the gene SMAD5 and glioblastoma.